Gosset Ownership
Private
Stage
Phase 2
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Nodenza Venture Partners General Information
Nodenza Venture Partners was launched in 2024 as a New York-based venture capital firm focused on investing globally in early-stage and pre-commercial biotech and medtech companies. The team consists of experienced life science entrepreneurs with deep expertise across drug development and commercialization. Their bi-modal strategy targets both new treatment modalities advancing from IND through Phase 2 as well as later-stage/pre-commercial opportunities transitioning toward market launch. They provide both financial backing and operational support to their portfolio companies.
Contact Information
Primary Industry
Investors
Corporate Office
New York, New York
United States
United States
Drug Pipeline
TRL1068
Phase 2Key Partnerships
Nodenza Venture Partners Funding
No funding data available
To view Nodenza Venture Partners's complete valuation and funding history, request access »